Steven Oh, PhD

Dr. Steven Oh is Deputy Director of Division of Cellular and Gene Therapies in CBER, FDA, and oversees all CMC review and regulatory activities for cell and gene therapy products, tissue-engineered products, and related medical devices used at the point-of-care. He is involved in developing CBER regulatory policies related to emerging advanced technologies, standards development and use, and global regulatory convergence in cell and gene therapies. Before joining the FDA in 2007, Dr. Oh served on the faculty of Tufts University School of Medicine. He was trained as a cell biologist and biochemist at Massachusetts Institute of Technology, Johns Hopkins University School of Medicine, and the University of Michigan.